Results 131 to 140 of about 18,145 (196)

Comparative efficacy and safety of Ranibizumab and Aflibercept for neovascular age-related macular degeneration: a systematic review and meta-analysis. [PDF]

BMC Ophthalmol
Zhao X, Yang Y.
europepmc   +1 more source

Treatment of spontaneous hyphema in Fuch's heterochromic iridocyclitis with intravitreal anti-VEGF ranibizumab. [PDF]

BMJ Case Rep
Guo G, Papantoniou L, Smith J, Ong K.
europepmc   +1 more source

Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trials. [PDF]

Br J Ophthalmol
Zhao S, Wu M, Zhong J, Chen B, Song Z, Ming Z, Han Q, Yu S, Wang H, Yuan S, Yao J, Zhao M, Meng X, Wang F, Lou J, Liu Y, Huang H, Zhou Q, Xu Y, Dai H, Li X.   +20 more
europepmc   +1 more source

The Evolving Role of Anti-VEGF Therapy in Proliferative Diabetic Retinopathy: Evidence, Challenges, and Future Directions. [PDF]

Clin Ophthalmol
Li J, Wang Y, Wang W, Zhang X, Cui T, Zhou G.   +5 more
europepmc   +1 more source

Optical Coherence Tomography Biomarkers as Potential Predictors for Visual Function and Response to Intravitreal Therapy in Diabetic Macular Edema. [PDF]

J Vitreoretin Dis
Mihalache A, Pandya BU, Jhaveri A, Pereira A, Tayeb S, Hurley B, Kherani A, You Y, Yan P.   +8 more
europepmc   +1 more source

Low Rates of Fibrosis in Eyes Treated with the Port Delivery Platform with Ranibizumab or with Monthly Ranibizumab in the Archway Trial. [PDF]

Ophthalmol Sci
Chakravarthy U, Gemmy Cheung CM, Staurenghi G, Sadda S, Guymer R, Jaffe GJ, Curcio CA, Holekamp NM, Bachmeier I, Scherb MP, Blotner S, Rabena M, Cordeiro MC, Armendariz BG, Kanku MS, Heinrich D.   +15 more
europepmc   +1 more source

Posterior segment inflammation with venous involvement following a switch to a ranibizumab biosimilar (Ximluci®): a case report. [PDF]

Am J Ophthalmol Case Rep
Conte S, Nassisi M, Mainetti C, Seregni L, Viola F.   +4 more
europepmc   +1 more source

Biosimilars of anti-VEGF agents in retinal diseases: a narrative review of regulatory, clinical, and pharmacoeconomic aspects. [PDF]

Int J Retina Vitreous
Zong Y, Fan Q, Huang L.
europepmc   +1 more source

Molecular Determinants of Intravitreal Anti-VEGF Durability: Drug Architecture, Intraocular Pharmacokinetics, Target Biology and Treatment Resistance. [PDF]

Int J Mol Sci
Panos GD, Empeslidis T, Amaxilati E, Tsiropoulos GN, Topouzis N, Konstas PAG, Chatzimichail E, Gatzioufas Z, Amoaku W.   +8 more
europepmc   +1 more source

Systemic Immune and miRNA Signatures Associated with Long-Term Ranibizumab Response in Neovascular Age-Related Macular Degeneration. [PDF]

Pharmaceuticals (Basel)
García-Quintanilla L, Almuiña-Varela P, Rodríguez-Cid MJ, Gil-Martinez M, Abraldes MJ, Gomez-Ulla F, González-Barcia M, Castro-Fernández DC, Cañizo-Outeiriño A, Cuartero-Martínez A, Estany-Gestal A, Otero-Espinar FJ, Fernández-Rodríguez M, Fernández-Ferreiro A.   +13 more
europepmc   +1 more source